Improving outcomes for patients with hip osteoarthritis - Hip Injection Trial (HIP)

Chief Investigator:

Dr Edward Roddy

Principal Investigator:

Dr Zoe Paskins

Study Co-ordinator:

Dr Andrea Cherrington

Funder name / reference number:National Institute for Health Research; Research For Patient Benefit, (PB-PG-0213-30027)
UKCRN Study portfolio:CPMS: 20242. 163306
Year2016 - 2018

Summary:

Study design

Improving outcomes for patients with hip osteoarthritis.

A randomised, clinical, single blind, three-arm, parallel group pragmatic trial with a linked qualitative study.

Primary objective

To compare the longitudinal mean pain scores over 6 months in people with hip osteoarthritis (OA)  receiving best current practice alone, with those receiving best current practice plus an ultrasound-guided corticosteroid + local anaesthetic (1% lidocaine hydrochloride)

Interventions

1. Best current treatment only

2. Best current treatment plus an ultrasound-guided intra-articular hip injection of corticosteroid (triamcinolone acetonide 40mg) with 1% lidocaine hydrochloride or

3. Best current treatment plus an ultrasound-guided intra-articular hip injection of 1% lidocaine hydrochloride alone